Groove Botanicals pivots to EV batteries with $2.7K cash, heavy related-party debts

Groove Botanicals, Inc. (PINK: GRVE) - quick read on what's happening inside the company and what the income statement really says.

What's happening inside
- Management pivot: company plans to assemble and commercialize early‑stage EV battery technologies sourced from universities in Norway, Sweden and Finland but currently owns no related patents or products.
- Funding source: operations are sustained by related‑party advances and accrued dividends to insiders; CEO Kent Rodriguez is the main financer and is the sole officer/director.
- Governance & controls: management admits material weaknesses - one-person finance team, no formal audit committee or financial expert; outside accounting help has been engaged.

Key facts & statistics (as reported, June 30, 2025)
- Cash: $2,737 (up from $2,042 at March 31, 2025).
- Total assets: $3,686 (March 31, 2025: $4,520).
- Total liabilities: $1,206,334 (March 31, 2025: $1,114,381).
- Related party payables: $641,314 (March 31, 2025: $608,833).
- Dividends payable (total): $326,869; dividends payable, related party: $164,688.
- Accumulated deficit: $(35,289,368) (March 31, 2025: $(35,196,581)).
- Stockholders' equity (deficit): $(1,202,648) (March 31, 2025: $(1,109,861)).
- Three‑month operating expenses (Q1 to June 30, 2025): $38,170 (2024: $36,539). Breakdown: SG&A $18,965; Legal & professional $15,605; Rent $3,600.
- Net loss for quarter: $(38,170) (2024: $(36,539)).
- Preferred dividends charged this quarter: $54,617 (unchanged vs prior).
- Net loss attributable to common shareholders (includes preferred dividends): $(92,787) (2024: $(91,156)).
- Weighted average common shares outstanding: 59,643,062; basic & diluted loss per share: $(0.00) (rounded).
- Net cash used in operating activities: $(19,786); net cash from financing (related party advances): $20,481; net change in cash: +$695.
- Accrued preferred dividends outstanding: Series A accrued $90,000; Series B accrued $401,558. Series A liquidation preference recorded at $500,000.

Positive aspects (income statement & cash flow)
- Operating expense control: total operating expenses rose only modestly (+$1,631 or ~4.5% year‑over‑year for the quarter).
- Short‑term cash improved slightly: cash increased by $695 during the quarter due to related‑party financing that covered operating cash burn.
- Non‑cash offsets: accruals (payroll) and working capital changes reduced cash burn vs net loss.

Negative aspects (income statement & balance sheet)
- No revenue: the company reports zero sales and does not expect near‑term product revenue.
- Recurring losses: net loss continues (Qtr: $(38k)); accumulated deficit exceeds $35 million - long history of losses.
- Heavy preferred dividend burden: $54,617 charged this quarter, materially increasing loss attributable to common shareholders (common holders bear the impact).
- Liabilities dwarf assets: total liabilities ($1.206M) vs total assets ($3,686) - balance sheet is extremely thin and relies on related‑party funding.
- Related party exposure: $641k payable to related parties and significant dividends payable to insider(s) - concentration and potential conflicts of interest.
- Going concern: auditors and management state substantial doubt about the company's ability to continue as a going concern without new financing (management says it needs $500k-$5M for planned strategy).
- Governance & disclosure risks: material weaknesses in internal control (single exec handling finance and disclosure); potential for delays or errors in reporting.

Operational & strategic risks
- Execution risk on pivot: plan to acquire/commercialize foreign university EV battery tech is unproven, likely capital intensive, and the company currently owns no IP.
- Financing risk: no current commitments for the $0.5M-$5M management says is needed; additional financing likely to dilute shareholders or add restrictive debt/terms.

Bottom line (straightforward)
- Groove Botanicals, Inc. (PINK: GRVE) is an OTC‑listed, early‑stage shell that is attempting a strategic pivot into EV battery technology but has no revenue, minimal cash ($2.7k), a meaningful accumulated deficit, and heavy related‑party funding and preferred dividend obligations. The near‑term viability depends entirely on securing outside capital or a material asset acquisition - both high risk. Investors should view this as speculative and capital‑dependent, with governance and going‑concern issues clearly disclosed by management.